A Corso, A Lorenzi, E Orlandi, C Astori, S Mangiacavalli and M Lazzarino (2002) “Advantages of using thalidomide for the management of refractory myeloma patients”, Haematologica. Pavia, Italy, 87(3), pp. 327-328. doi: 10.3324/%x.